Global Extracorporeal Membrane Oxygenation Machine Report Thumbnail

Global Extracorporeal Membrane Oxygenation Machine Market by Component (Pumps, Oxygenator) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: MD-72851
  • Author: Up Market Research
  • Rating: 4.6
  • Total Reviews: 98
  • No. Of Pages: 220
  • Format:
  • Pub. Date: 2021-10-21
  • Share:

Summary of the Report

Global extracorporeal membrane oxygenation machines market was valued at USD 202.6 millions in 2020. It is expected to grow at a compound annual rate (CAGR of 5.1%) between 2021 and 2028. Extracorporeal membrane oxygenation market (ECMO), is driven by the rising incidence of cardiovascular disease and respiratory failure. According to the Centers for Disease Control and Prevention, a person dies from cardiovascular disease every 37 seconds in the United States. In 2018, the number one cause of death in the U.S. was chronic obstructive lung disease (COPD). The market is growing due to the increasing number of hospitals that offer ECMO services, and the increase in awareness programs. According to the Federal Agency of Health Research and Quality in 2014, there were 6890 ECMO operations performed in the U.S. Since then, ECMO machines have been adopted in more hospitals.

Extracorporeal Life Support Organization, (ELSO) reports that 264 hospitals offered ECMO services in 2019, up from 108 in 2008. ECMO devices can be used to treat serious COVID-19 cases. In 2020, however, the market for other uses of these devices (e.g. heart procedures) declined sharply. The market is also growing due to increasing awareness of ECMO procedures, and technological advancements. Many government agencies are working to raise awareness about ECMO Procedures. Initiatives like the Global Initiative for Chronic Obstructive Leng Disease (GOLD), which aims to raise awareness about COPD and its treatment, including the use of ECMO devices, are a part of the Global Initiative for Chronic Obstructive Lung Disease.

The increasing use of ECMO machines is also driving technological innovation in these systems. These include oxygenators, hollow pumps, heparin-coated catheters, and other applications for surgeries. The ECMO machines that have been recently developed are also smaller, making them more portable and easier to use. ECMO machines can also be transported by using portable adaptors or compact circuits.

Impact of COVID19: Market fell by approximately 25% starting in 2019

Pandemic Impact

Outlook after COVID

ECMO machines are a lifesaver to severe COVID-19 sufferers. However, strict regulations limit their use.

From 2021 to 2028, the demand for ECMO devices is expected to rise at a rate of more than 5%. Major hospitals stocking up on ECMO devices in case of pandemics is likely to drive the growth.

During the pandemic, the overall market experienced a 70% drop in its value.

Multiple studies have shown that patients with COVID-19 will likely experience a decline in immunity and long-term symptoms, which could lead to an increase in organ failure and increased demand for ECMO devices.

The increasing number of people over 65 and the rising incidence of coronary disease are driving the growth of ECMO machines. The leading cause of death in the world is coronary heart disease, which is strongly linked to age. The United Nations projects that the number of people over 80 years old will rise to 426 million by 2050, from 143 million globally in 2019. The market may be limited by complications such as bleeding, technical failures, infections and high costs of treatment.

Component Insights

The oxygenator segment held 34.1% of the market share in 2020, and it is expected to continue growing at a rapid pace during the forecast period. The high price and the acute exchange rate for an alternative system is what explains the large market share of oxygenator. Mechanical failure, pump head and acute oxygenator complications are the main causes of low exchange rates for oxygenator.

Due to its high price and widespread usage, the pumps segment held a significant market share in 2020. Pumps in ECMO machines are used to pump blood from a patient into artificial lungs, which then send it back to the patient. This segment has seen a lot of growth due to the large use of pumps in ECMO procedures. There are many types of pumps available, including impeller, roller and centrifugal. These pumps can be used for various ECMO procedures depending on their needs.

Modality Insights

In 2020, the veno-arterial segment held 41.8% of the market and is expected grow at a healthy CAGR over the forecast period. Its high use in treating cardiac arrest patients and assisting with algorithm-based strategies to restore blood flow is what accounts for the largest segment.

In 2020, the veno-venous segment accounted for a large share and is expected to continue growing at a rapid pace during the forecast period. The veno-venous ECMO circuit (VV ECMO), serves the primary purpose of facilitating the exchange of oxygen and carbon dioxide. It is therefore a very important application for cases in which lung support is required. This segment is driven by the increasing prevalence of chronic obstructive lung disease. The WHO estimates that there were 251,000,000 cases of COPD worldwide in 2016, and this number will continue to rise over the forecast period.

Application Insights

In 2020, the respiratory segment held 43.9% of the market share. This segment is driven by the rising prevalence of respiratory diseases and increased awareness of ECMO procedures. The ELSO published statistics showing that more than 2,600 people with respiratory diseases in the U.S. received ECMO treatment in 2015.

Due to increasing cardiac surgery rates and increased awareness about ECMO machines in heart surgery, the segment of cardiac surgery accounted for a significant market share in 2020. According to the American Heart Association in 2016, approximately one in three deaths in America was due to cardiovascular disease. The segment will be driven by the rising cost of ECMO procedures, particularly in cardiac surgery. A study found that the direct medical costs for cardiovascular diseases will reach USD 749 millions by 2035.

Patient Type Insights

In 2020, the adult segment was responsible for the largest percentage of 59.0% and it is expected to grow at a faster rate over the forecast period. The global burden of respiratory and cardiac diseases is rising in adults due to increased consumption of alcohol, tobacco and smoking. The Extracorporeal Life Support Organization released a report that showed that there were approximately 7,850 people with cardiac diseases in January 2016.

The market share held by the pediatric segment was substantial and will continue to grow during the forecast period. One of the main drivers for this segment is the increasing number of children suffering from various pulmonary diseases. Extracorporeal Life Support Organization estimates that around 8.102 children were affected by cardiac disease in January 2016. These children required ECMO therapy.

Regional Insights

North America held a 39.8% market share in 2020, thanks to major players and increasing product launches. This market has grown due to government support for high quality healthcare, high purchasing power parity and increasing incidence of diseases such as chronic obstructive lung disease in Canada and the U.S. Hospital admissions have increased due to the availability of high-quality healthcare facilities and favorable reimbursement policies. This will in turn increase the region's usage.

Asia Pacific will experience the fastest growth over the forecast period. The growth of this market is fueled by a rise in healthcare spending by both the government and private entities to improve healthcare facilities. Market growth will also be supported by rising economic development in countries like Japan, India and China.

Market Share Insights & Key Companies

Technology collaboration is a key focus for major players. Terumo Cardiovascular Systems Corporation, for instance, launched the CAPIOX FX advanced oxygenator in February 2016. The advanced features of this device include a 3,000ml reservoir, increased blood flow rate, and improved flow dynamics. These launches are more efficient and help to support market growth. The market leader in extracorporeal membrane oxygenation machines is:

  • Medtronic plc

  • Sorin Group

  • Terumo Cardiovascular Systems Corporation

  • MAQUET Holding B.V. & Co. KG

  • Medos Medizintechnik AG

  • Nipro Medical Corporation

  • Microport Scientific Corporation

Up Market Research published a new report titled “Extracorporeal Membrane Oxygenation Machine Market research report which is segmented by Component (Pumps, Oxygenator), By Players/Companies MAQUET Holding BV & Co KG, Terumo Cardiovascular Systems Corporation, Medtronic plc, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report Scope

Report AttributesReport Details
Report TitleExtracorporeal Membrane Oxygenation Machine Market Research Report
By ComponentPumps, Oxygenator
By CompaniesMAQUET Holding BV & Co KG, Terumo Cardiovascular Systems Corporation, Medtronic plc, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages220
Number of Tables & Figures154
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Extracorporeal Membrane Oxygenation Machine Industry Outlook

Global Extracorporeal Membrane Oxygenation Machine Market Report Segments:

The market is segmented by Component (Pumps, Oxygenator).

Extracorporeal Membrane Oxygenation Machine Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Extracorporeal Membrane Oxygenation Machine Market

Overview of the regional outlook of the Extracorporeal Membrane Oxygenation Machine Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Extracorporeal Membrane Oxygenation Machine Market Overview

Highlights of The Extracorporeal Membrane Oxygenation Machine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Extracorporeal Membrane Oxygenation Machine Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
        6. By Component:

                1. Pumps

                2. Oxygenator

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Extracorporeal Membrane Oxygenation Machine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Extracorporeal Membrane Oxygenation Machine Market Trends

Reasons to Purchase the Extracorporeal Membrane Oxygenation Machine Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Extracorporeal Membrane Oxygenation Machine Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Extracorporeal Membrane Oxygenation Machine Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Extracorporeal Membrane Oxygenation Machine Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Extracorporeal Membrane Oxygenation Machine Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Extracorporeal Membrane Oxygenation Machine Market Size & Forecast, 2018-2028 
      4.5.1 Extracorporeal Membrane Oxygenation Machine Market Size and Y-o-Y Growth 
      4.5.2 Extracorporeal Membrane Oxygenation Machine Market Absolute $ Opportunity 


Chapter 5 Global Extracorporeal Membrane Oxygenation Machine Market Analysis and Forecast by Component
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Component
      5.1.2 Basis Point Share (BPS) Analysis by Component
      5.1.3 Absolute $ Opportunity Assessment by Component
   5.2 Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Component
      5.2.1 Pumps
      5.2.2 Oxygenator
   5.3 Market Attractiveness Analysis by Component

Chapter 6 Global Extracorporeal Membrane Oxygenation Machine Market Analysis and Forecast by Region
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Region
      6.1.2 Basis Point Share (BPS) Analysis by Region
      6.1.3 Absolute $ Opportunity Assessment by Region
   6.2 Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Region
      6.2.1 North America
      6.2.2 Europe
      6.2.3 Asia Pacific
      6.2.4 Latin America
      6.2.5 Middle East & Africa (MEA)
   6.3 Market Attractiveness Analysis by Region

Chapter 7 Coronavirus Disease (COVID-19) Impact 
   7.1 Introduction 
   7.2 Current & Future Impact Analysis 
   7.3 Economic Impact Analysis 
   7.4 Government Policies 
   7.5 Investment Scenario

Chapter 8 North America Extracorporeal Membrane Oxygenation Machine Analysis and Forecast
   8.1 Introduction
   8.2 North America Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Country
      8.2.1 U.S.
      8.2.2 Canada
   8.3 Basis Point Share (BPS) Analysis by Country
   8.4 Absolute $ Opportunity Assessment by Country
   8.5 Market Attractiveness Analysis by Country
   8.6 North America Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Component
      8.6.1 Pumps
      8.6.2 Oxygenator
   8.7 Basis Point Share (BPS) Analysis by Component 
   8.8 Absolute $ Opportunity Assessment by Component 
   8.9 Market Attractiveness Analysis by Component

Chapter 9 Europe Extracorporeal Membrane Oxygenation Machine Analysis and Forecast
   9.1 Introduction
   9.2 Europe Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Country
      9.2.1 Germany
      9.2.2 France
      9.2.3 Italy
      9.2.4 U.K.
      9.2.5 Spain
      9.2.6 Russia
      9.2.7 Rest of Europe
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 Europe Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Component
      9.6.1 Pumps
      9.6.2 Oxygenator
   9.7 Basis Point Share (BPS) Analysis by Component 
   9.8 Absolute $ Opportunity Assessment by Component 
   9.9 Market Attractiveness Analysis by Component

Chapter 10 Asia Pacific Extracorporeal Membrane Oxygenation Machine Analysis and Forecast
   10.1 Introduction
   10.2 Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Country
      10.2.1 China
      10.2.2 Japan
      10.2.3 South Korea
      10.2.4 India
      10.2.5 Australia
      10.2.6 South East Asia (SEA)
      10.2.7 Rest of Asia Pacific (APAC)
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Component
      10.6.1 Pumps
      10.6.2 Oxygenator
   10.7 Basis Point Share (BPS) Analysis by Component 
   10.8 Absolute $ Opportunity Assessment by Component 
   10.9 Market Attractiveness Analysis by Component

Chapter 11 Latin America Extracorporeal Membrane Oxygenation Machine Analysis and Forecast
   11.1 Introduction
   11.2 Latin America Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Country
      11.2.1 Brazil
      11.2.2 Mexico
      11.2.3 Rest of Latin America (LATAM)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Latin America Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Component
      11.6.1 Pumps
      11.6.2 Oxygenator
   11.7 Basis Point Share (BPS) Analysis by Component 
   11.8 Absolute $ Opportunity Assessment by Component 
   11.9 Market Attractiveness Analysis by Component

Chapter 12 Middle East & Africa (MEA) Extracorporeal Membrane Oxygenation Machine Analysis and Forecast
   12.1 Introduction
   12.2 Middle East & Africa (MEA) Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Country
      12.2.1 Saudi Arabia
      12.2.2 South Africa
      12.2.3 UAE
      12.2.4 Rest of Middle East & Africa (MEA)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Middle East & Africa (MEA) Extracorporeal Membrane Oxygenation Machine Market Size Forecast by Component
      12.6.1 Pumps
      12.6.2 Oxygenator
   12.7 Basis Point Share (BPS) Analysis by Component 
   12.8 Absolute $ Opportunity Assessment by Component 
   12.9 Market Attractiveness Analysis by Component

Chapter 13 Competition Landscape 
   13.1 Extracorporeal Membrane Oxygenation Machine Market: Competitive Dashboard
   13.2 Global Extracorporeal Membrane Oxygenation Machine Market: Market Share Analysis, 2019
   13.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      13.3.1 MAQUET Holding BV & Co KG
      13.3.2 Terumo Cardiovascular Systems Corporation
      13.3.3 Medtronic plc
      13.3.4 Nipro Medical Corporation
      13.3.5 Microport Scientific Corporation
      13.3.6 Medos Medizintechnik AG
      13.3.7 Sorin Group
Segments Covered in the Report
The global Extracorporeal Membrane Oxygenation Machine market has been segmented based on

By Component
  • Pumps
  • Oxygenator
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • MAQUET Holding BV & Co KG
  • Terumo Cardiovascular Systems Corporation
  • Medtronic plc
  • Nipro Medical Corporation
  • Microport Scientific Corporation
  • Medos Medizintechnik AG
  • Sorin Group

Buy Report